Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Narcolepsy
Thomas E. Scammell
New England Journal of Medicine (2015) Vol. 373, Iss. 27, pp. 2654-2662
Closed Access | Times Cited: 423

Showing 1-25 of 423 citing articles:

Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial
Zoltán Szakács, Yves Dauvilliers, V. I. Mikhaylov, et al.
The Lancet Neurology (2017) Vol. 16, Iss. 3, pp. 200-207
Closed Access | Times Cited: 317
T cells in patients with narcolepsy target self-antigens of hypocretin neurons
Daniela Latorre, Ulf Kallweit, Eric Armentani, et al.
Nature (2018) Vol. 562, Iss. 7725, pp. 63-68
Closed Access | Times Cited: 298
The Biology of REM Sleep
John Peever, Patrick M. Fuller
Current Biology (2017) Vol. 27, Iss. 22, pp. R1237-R1248
Open Access | Times Cited: 283
Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea
Atul Malhotra, Colin M. Shapiro, Jean‐Louis Pépin, et al.
SLEEP (2019) Vol. 43, Iss. 2
Open Access | Times Cited: 234
Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study
Yves Dauvilliers, Isabelle Arnulf, Zoltán Szakács, et al.
SLEEP (2019) Vol. 42, Iss. 11
Open Access | Times Cited: 230
The neurobiological basis of narcolepsy
Carrie E. Mahoney, Andrew C. Cogswell, Igor J. Koralnik, et al.
Nature reviews. Neuroscience (2018) Vol. 20, Iss. 2, pp. 83-93
Open Access | Times Cited: 216
Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy
Beatrice Setnik, Michael McDonnell, Catherine Mills, et al.
SLEEP (2019) Vol. 43, Iss. 4
Open Access | Times Cited: 183
Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease
Jonathan Cedernaes, Ricardo S. Osorio, Andrew W. Varga, et al.
Sleep Medicine Reviews (2016) Vol. 31, pp. 102-111
Open Access | Times Cited: 174
Catatonia and the immune system: a review
Jonathan Rogers, Thomas A. Pollak, Graham Blackman, et al.
The Lancet Psychiatry (2019) Vol. 6, Iss. 7, pp. 620-630
Open Access | Times Cited: 170
Hyperexcitable arousal circuits drive sleep instability during aging
Shi‐Bin Li, Valentina Martínez Damonte, Chong Chen, et al.
Science (2022) Vol. 375, Iss. 6583
Open Access | Times Cited: 127
Orexin neurons inhibit sleep to promote arousal
Roberto De Luca, Stefano Nardone, Kevin P. Grace, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 69
Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1
Yves Dauvilliers, Emmanuel Mignot, Rafael del Río Villegas, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 4, pp. 309-321
Closed Access | Times Cited: 40
The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress
Miklós Jászberényi, Balázs Thurzó, Zsolt Bagosi, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 448-448
Open Access | Times Cited: 22
Sleep Disturbance and Pain
Mônica L. Andersen, Paula Araujo, Cristina Frange, et al.
CHEST Journal (2018) Vol. 154, Iss. 5, pp. 1249-1259
Closed Access | Times Cited: 158
Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models
Yoko Irukayama‐Tomobe, Yasuhiro Ogawa, Hiromu Tominaga, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 22, pp. 5731-5736
Open Access | Times Cited: 126
High-dimensional single-cell analysis reveals the immune signature of narcolepsy
Felix J. Hartmann, Raphaël Bernard‐Valnet, Clémence Quériault, et al.
The Journal of Experimental Medicine (2016) Vol. 213, Iss. 12, pp. 2621-2633
Open Access | Times Cited: 115
To eat or to sleep: That is a lateral hypothalamic question
Elda Arrigoni, Melissa J. Chee, Patrick M. Fuller
Neuropharmacology (2018) Vol. 154, pp. 34-49
Closed Access | Times Cited: 115
Real-time dialogue between experimenters and dreamers during REM sleep
Karen Konkoly, Kristoffer Appel, Emma Chabani, et al.
Current Biology (2021) Vol. 31, Iss. 7, pp. 1417-1427.e6
Open Access | Times Cited: 99
Treatment Options for Narcolepsy
Lucie Barateau, Régis Lopez, Yves Dauvilliers
CNS Drugs (2016) Vol. 30, Iss. 5, pp. 369-379
Closed Access | Times Cited: 93
Clinical Characteristics and Burden of Illness in Pediatric Patients with Narcolepsy
Giuseppe Plazzi, Heather M. Clawges, Judith Owens
Pediatric Neurology (2018) Vol. 85, pp. 21-32
Open Access | Times Cited: 91
Recent advances in treatment for narcolepsy
Lucie Barateau, Yves Dauvilliers
Therapeutic Advances in Neurological Disorders (2019) Vol. 12
Open Access | Times Cited: 84
The orexin story and orexin receptor antagonists for the treatment of insomnia
Clemens Muehlan, Catherine Roch, Cédric Vaillant, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 6
Open Access | Times Cited: 39
Association of lifestyle with sleep health in general population in China: a cross-sectional study
Yongbo Zheng, Yuetong Huang, Yi-Miao Gong, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Identification of bidirectional causal links between gut microbiota and narcolepsy type 1 using Mendelian randomization
Dandan Sheng, Peihong Li, Zheng Xiao, et al.
SLEEP (2024) Vol. 47, Iss. 3
Closed Access | Times Cited: 8
Narcolepsy: Beyond the Classic Pentad
Anne Marie Morse, Sooyoung Kim, Shelby Freedman Harris, et al.
CNS Drugs (2025)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top